The Treatment Landscape of Duchenne Muscular Dystrophy, Highlighting Elevidys, the Newly Approved Recombinant Gene Therapy

from American Association of Neuromuscular & Electrodiagnostic Medicine (AANEM) · host AANEM

Dr. Rothman interviews Drs. Stratton and Yang to discuss the treatment landscape of Duchenne Muscular Dystrophy, highlighting Elevidys, the newly approved recombinant gene therapy.

Episode metadata supplied by the publisher feed · Published Oct 9, 2023

Embed this episode

Attribution link and audio player

NOW PLAYING

The Treatment Landscape of Duchenne Muscular Dystrophy, Highlighting Elevidys, the Newly Approved Recombinant Gene Therapy

0:00 27:43

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of American Association of Neuromuscular & Electrodiagnostic Medicine (AANEM)?

This episode is 27 minutes long.

When was this American Association of Neuromuscular & Electrodiagnostic Medicine (AANEM) episode published?

This episode was published on October 9, 2023.

Can I download this American Association of Neuromuscular & Electrodiagnostic Medicine (AANEM) episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!